Neuphoria Therapeutics (NEUP) Assets Average (2021 - 2026)
Neuphoria Therapeutics (NEUP) reported Assets Average of $35.7 million for Q1 2026, up 46.08% year-over-year from $24.4 million in Q1 2025, and up 11.68% on a QoQ basis from $32.0 million in Q4 2025.
Neuphoria Therapeutics (NEUP) has 6 years of Assets Average data on file, last reported at $35.7 million in Q1 2026.
- Quarterly Assets Average rose 46.08% year-over-year to $35.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $35.7 million (up 46.08% YoY) and the FY2025 annual result came in at $28.1 million, changed 0.05% from the prior year.
- Assets Average grew to $35.7 million in Q1 2026 per NEUP's latest filing, from $32.0 million in the prior quarter.
- Across five years, Assets Average topped out at $48.1 million in Q2 2022 and bottomed at $20.5 million in Q4 2024.
- The 5-year median for Assets Average is $29.7 million (2025), against an average of $31.3 million.
- The widest annual swing landed in 2022, when Assets Average soared 126.35%; it then slipped 21.5% in 2023.
- Tracing NEUP's Assets Average over 5 years: stood at $48.1 million in 2022, then declined by 21.5% to $37.8 million in 2023, then slumped by 45.6% to $20.5 million in 2024, then soared by 55.63% to $32.0 million in 2025, then grew by 11.68% to $35.7 million in 2026.
- Per Business Quant, the three latest NEUP Assets Average figures stand at $35.7 million (Q1 2026), $32.0 million (Q4 2025), and $28.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13.04 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 33.42 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.72 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 331.70 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 40.89 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 26.06 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 26.03 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 40.71 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 5.05 Bn |
| 10 | Neuphoria Therapeutics | 28.35 Mn | 8.95 Mn | - | 35.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.70 Mn |
| Dec 31, 2025 | 31.97 Mn |
| Sep 30, 2025 | 27.97 Mn |
| Jun 30, 2025 | 29.65 Mn |
| Mar 31, 2025 | 24.44 Mn |
| Dec 31, 2024 | 20.54 Mn |
| Sep 30, 2024 | 25.28 Mn |
| Jun 30, 2023 | 37.76 Mn |
| Jun 30, 2022 | 48.10 Mn |
| Dec 31, 2021 | 45.60 Mn |
| Jun 30, 2021 | 21.25 Mn |